IFNG and cancer: Crucially, PD-L1 can be upregulated in cancer cells upon interferon-γ (IFN-γ) stimulation and some activated immune cells (e.g., macrophages, dendritic cells) (Dong et al., 1999), indicating the major regulator role of PD-L1 in cancer tissues.